SIGI
ORMP icon

Susquehanna International Group (Ireland)’s Oramed Pharmaceuticals ORMP Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-113,526
Closed -$247K – 75
2023
Q1 		$247K Buy
+113,526
New +$361K 0.14% 46
2022
Q1 		– Sell
-13,539
Closed -$178K – 85
2021
Q4 		$178K Buy
+13,539
New +$283K 0.07% 55

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Susquehanna International Group (Ireland)'s ORMP Position: Q2 2023 in Review

Susquehanna International Group (Ireland) sold out of Oramed Pharmaceuticals (ORMP) in Q2 2023, closing a stake of 113,526 shares — an estimated $247K sold.

Susquehanna International Group (Ireland) first reported a position in ORMP in Q4 2021 and held it in 2 quarters. The position peaked at $247K in Q1 2023. 50 funds tracked by Wall St. Rank hold ORMP as of Q2 2023.

  • Susquehanna International Group (Ireland) reported no remaining Oramed Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 113,526 Oramed Pharmaceuticals shares in Q2 2023, an estimated $247K.
  • Susquehanna International Group (Ireland) first reported a position in Oramed Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Susquehanna International Group (Ireland)'s Oramed Pharmaceuticals position peaked at $247K in Q1 2023.
  • 50 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2023.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q2 2023, filed 11 Aug 2023.